Neoplasia Flashcards

1
Q

Tumour definition

A

Mass or swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Neoplasm

A

Abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in the same excessive manner after cessation of the stimuli which evoked the change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define benign

A

Neoplasm which is localised and cannot spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define malignant

A

Neoplasm which can invade and destroy adjacent structures and spread to distant sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define cancer

A

Malignant neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define metastasis

A

Spread of a cancer to a distant site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the normal cell turnover and healing and repair

A

The cells proliferate to replace damaged or apoptotic cells

And once the tissue has regained its normal structure proliferation ceases - no mutations have occurred

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a clinically irrelevant mutation

A

By chance a cell may develop a mutation which does not confer a survival advantage
So proliferated but the irrelevant mutation does not dominate since they have no survival advantage over the normal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens in a benign neoplasia

A

A neoplasm is formed by the clinal expansion of a single precursor cell that has a survival advantage over its neighbours
In the pretumoural stageneoplastic mutations are present in the tissue, but have not yet given rise to a tumour. These are typically clinically silent
Over time the neoplastic clone dominates the tissue and forms a mass. Cells do not have malignant capacity so is a benign tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where do benign tumour go

A
Nowhere they are limited to the site of origin, but show expansive growth and do not metastasise
Often clinically irrelevant but 
Can cause 
Compression
Obstruction
Bleeding
Hormone secretion
Cosmetic effect 
Progression to malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is in situ neoplasia

A
Some mutations (arising either de novo or in benign neoplasm) give cells malignant capacity 
The malignant phenotype comes to dominate the tissue , but so far the cells have not actually invaded the basement membranes
So is in situ malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where does in situ neoplasia go

A

Biologically has malignant potential , but has not yet invaded beyond the confines of the normal tissue e.g. Basement membrane
Can be considered pre cancerous
Complete excision is curative
Often asymptomatic as does not form a mass
Important for screening programmes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cancer is

A

Cells with a malignant phenotype that invade local structures and spread through tissues
Invasive malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is cancer

A

Malignant neoplasm
Has the ability to invade and destroy
Capacity to invade and destroy adjacent tissues
Has the capacity to metastasise
Metastasis invade and destroy adjacent tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hallmarks of cancer

A
Sustaining proliferative potential 
Evading growth suppressors 
Avoiding immune destruction
Enabling replicative immortality 
Tumour promoting inflammation
Activating invasion and metastasis 
Inducing angiogenesis
Genome instability and mutation 
Resisting cell death
Deregulating cellular energetics
Sustaining proliferative signalling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where are the most likely met sites

A

Lymph nodes from lymph vessel spread

Blood vessels to liver, bone marrow, brain, lung, kidney and adrenal

17
Q

Pathogenesis of cancer

A

Genetics and environmental factors

18
Q

Genetics role in cance r

A

Inherited cancer syndromes - Li Fraumeni

Familial cancers - higher frequency in some families without a clearly defined pattern of transmission

19
Q

Environmental factors role in cancer

A
UV rays
Ionising radiation
Viruses
Tissue inflammation
Occupational exposure
Carcinogens
20
Q

Clinical effects of cancer

A

Compression
Obstruction
Bleeding
Local destruction of tissues
Paraneoplastic syndromes
- hormone mediated Cushing said due to ACTH like substance released in lung cancer
- immunologically mediated - lambert Easton syndrome- caused by antibodies against presynaptic voltage gated calcium channels at the NMJ causing severe muscle weakness
Cachexia TNF produced by peritumoural macrophages and some tumour cells mobilises fat from tissue and suppresses appetite
Pain
Death

21
Q

What types of histopathology are submitted

A

Cytology - a fluid sample of tumour looking for cells
Biopsy - solid sample of tumour - cells
Excision - surgical removal of the whole tumour

22
Q

Types of examination of the histopathology sample submitted

A

Macroscopic examination
Microscopic examination
Special tests - immunohistochemistry FISH PCR

23
Q

Role of the histopathologist in managing neoplasia

A
Provide a diagnosis 
- benign/ in situ/ malignant 
- classification 
Provide prognostic info
- tumour grade, vascular invasion, perineural invasion, extent of invasion, tumour stage 
Provide predictive info
- testing the neoplasm for markers of responsiveness to specific therapies 
Screening
24
Q

Benign macroscopic shapes

A

Sessile
Pedunculated
Papillary

25
Q

Malignant macroscopic shapes

A

Fungating
Ulcerated
Annular

26
Q

Microscopic features of benign neoplasms

A
Resemblance to normal tissue 
Circumscribed tumour border
No invasion
Often no hyperchromasia
Regular nuclear border
No pleomorphism 
No prominent nucleoli 
Low mitotic activity
27
Q

Malignant neoplasms microscopic features

A
Poor resemblance to normal tissue 
Poorly defined tissue border
Invasion
Hyperchromasia
Irregular nuclear border
Pleomorphism 
Prominent nucleoli
High mitotic activity
28
Q

Factors involved in classification

A
Behaviour and site
Benign or malignant 
And where
Cell of origin
Epithelia 
Mesenchymal
29
Q

Classification terminology

A

Suffix oma
Malignant epithelial original carcincoma
Malignant mesenchymal origin sarcoma

30
Q

What are the pathological prognostic features

A

Tumour invasiveness
- depth of invasion, vascular invasion, perinueural invasion
Grade
- degree of histological resemblance to parent tissue
Stage
- extent of anatomical spread

31
Q

Depth of invasion of a malignant melanoma

A

Breslows depth

Imp prognostically

32
Q

Grade defined by

Adenocarcinoma

A

Gleasons pattern
Less like original more poor prognosis
Gleason score
Sum of two commonest Gleason patterns on the tumour imp progonsis in prostatic adenocarcinoma

33
Q

What does tumour grade categorise by

A

Extent of the invasion

34
Q

What does TNM stand for

A

T tumour size and extent of local invasion
N degree of spread to regional lymph nodes
M presence or absence of distant mets

Prefix p means done by a pathologist rather than clinically or radiological

35
Q

Other staging system in colorectal

A

Dukes staging

36
Q

Types of predictive tests

A

Immunohistochemistry for hormone receptors in breast cancer
FISH fluorescence in situ hybridisation for gene rearrangemt in lung cancer
PCR based methods for mutations in colorectal cancer

37
Q

Screening basis

A

Concept of detecting carcinoma in situ
Before it is invasive
Pathologists are involved in programmes for cervical, breast and colorectal cancers